Key result
Transcutaneous auricular vagus nerve stimulation enhanced the willingness to exert effort for rewards compared to sham, particularly in individuals with higher depressive symptoms.
Why the study?
Anhedonia in major depressive disorder is associated with disrupted reward processing and may be a mechanistically relevant target for neuromodulation.
Does transcutaneous auricular vagus nerve stimulation improve reward-related behavior and autonomic regulation in individuals with depressive symptomatology?
RCT (n=68)
randomized
Does transcutaneous auricular vagus nerve stimulation improve reward-related behavior and autonomic regulation in individuals with depressive symptomatology?
Transcutaneous auricular vagus nerve stimulation modulates motivational effort allocation and heart rate variability, suggesting potential utility for targeting reward-related dysfunctions in mood disorders.
Answers are grounded in this paper and cite their sources.
taVNS may target motivational deficits in depression; extends RCT evidence for non-invasive neuromodulation of reward behavior.
Anhedonia, a core feature of major depressive disorder, is associated with disrupted reward processing and may represent a mechanistically relevant target for neuromodulation. This study examined the effects of transcutaneous auricular vagus nerve stimulation (taVNS) on reward-related behavior and autonomic regulation in individuals with higher (n = 34) and lower (n = 34) depressive symptomatology. In a randomized, within-subject crossover design, participants received active taVNS and sham stimulation on two separate days. During each session, incentive motivation and reward learning were assessed using the Effort Expenditure for Rewards Task and the Probabilistic Reward Task (PRT), respectively, with stimulation condition and task order counterbalanced. Findings revealed that taVNS effects on heart rate variability (HRV) were modulated by baseline HRV levels and depressive status; specifically, they enhanced HRV at low baseline levels and reduced it at high baseline levels in participants with lower depressive symptomatology, with opposite patterns in individuals with higher symptoms. Moreover, compared to sham, taVNS enhanced the willingness to exert effort for rewards, particularly at low reward probabilities, with a more pronounced effect in the group characterized by higher depressive symptoms. No significant effects were observed on reward learning, as indexed by the PRT. Additionally, taVNS reduced self-reported anxiety across groups. Despite the limitation of a single stimulation session, these findings suggest that taVNS modulates motivational effort allocation in individuals with higher depressive symptoms, supporting its potential relevance for targeting reward-related dysfunctions in mood disorders.
No takes yet. Share an insight, caveat, or question.
Grimaldi et al. (2026) conducted an RCT in Depressive symptomatology and anhedonia (n=68). Transcutaneous auricular vagus nerve stimulation (taVNS) vs. Sham stimulation was evaluated on Incentive motivation and reward learning. Transcutaneous auricular vagus nerve stimulation enhanced the willingness to exert effort for rewards compared to sham, particularly in individuals with higher depressive symptoms.
Synapse has enriched 10 related papers. Consider them for comparative context: